BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 17335678)

  • 1. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
    Smith T; Befeler AS
    Curr Gastroenterol Rep; 2007 Mar; 9(1):54-9. PubMed ID: 17335678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
    Holtmeier J; Leuschner U
    Digestion; 2001; 64(3):137-50. PubMed ID: 11786661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of cholestatic disease in 2017.
    de Vries E; Beuers U
    Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
    Mitchell SA; Bansi DS; Hunt N; Von Bergmann K; Fleming KA; Chapman RW
    Gastroenterology; 2001 Oct; 121(4):900-7. PubMed ID: 11606503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary sclerosing cholangitis.
    Stiehl A; Benz C; Sauer P
    Can J Gastroenterol; 2000 Apr; 14(4):311-5. PubMed ID: 10799084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of cholestatic liver diseases].
    Gatzen M; Pausch J
    Med Klin (Munich); 2002 Mar; 97(3):152-9. PubMed ID: 11957790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The medical management of primary sclerosing cholangitis.
    Michaels A; Levy C
    Medscape J Med; 2008 Mar; 10(3):61. PubMed ID: 18449341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis.
    Triantos CK; Koukias NM; Nikolopoulou VN; Burroughs AK
    Aliment Pharmacol Ther; 2011 Oct; 34(8):901-10. PubMed ID: 21883323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response.
    van de Meeberg PC; Wolfhagen FH; Van Berge-Henegouwen GP; Salemans JM; Tangerman A; van Buuren HR; van Hattum J; van Erpecum KJ
    J Hepatol; 1996 Dec; 25(6):887-94. PubMed ID: 9007717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Therapies for Chronic Cholestatic Liver Diseases.
    Wagner M; Fickert P
    Annu Rev Pharmacol Toxicol; 2020 Jan; 60():503-527. PubMed ID: 31506007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary sclerosing cholangitis: updates in diagnosis and therapy.
    Portincasa P; Vacca M; Moschetta A; Petruzzelli M; Palasciano G; van Erpecum KJ; van Berge-Henegouwen GP
    World J Gastroenterol; 2005 Jan; 11(1):7-16. PubMed ID: 15609388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary sclerosing cholangitis and bile acids.
    Chazouillères O
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S21-5. PubMed ID: 23141889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sclerosing cholangitis.
    Zein CO; Lindor KD
    Semin Gastrointest Dis; 2001 Apr; 12(2):103-12. PubMed ID: 11352117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
    Lindor KD; Kowdley KV; Luketic VA; Harrison ME; McCashland T; Befeler AS; Harnois D; Jorgensen R; Petz J; Keach J; Mooney J; Sargeant C; Braaten J; Bernard T; King D; Miceli E; Schmoll J; Hoskin T; Thapa P; Enders F
    Hepatology; 2009 Sep; 50(3):808-14. PubMed ID: 19585548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis.
    Zein CO; Lindor KD
    Curr Gastroenterol Rep; 2010 Feb; 12(1):13-22. PubMed ID: 20425480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acids for primary sclerosing cholangitis.
    Poropat G; Giljaca V; Stimac D; Gluud C
    Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD003626. PubMed ID: 21249655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Primary Sclerosing Cholangitis Including Transplantation.
    Wheless WH; Russo MW
    Clin Liver Dis; 2024 Feb; 28(1):171-182. PubMed ID: 37945158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of primary sclerosing cholangitis.
    Floreani A; De Martin S
    Dig Liver Dis; 2021 Dec; 53(12):1531-1538. PubMed ID: 34011480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.